However, this new rapid antidepressant could change that ... and rapid antidepressant that challenges everything else on the market right now. Josh Hawkins has been writing for over a decade ...

Since the 1980s, selective serotonin reuptake inhibitor (SSRI) antidepressants have been the ... SSRIs and proposing the use of these drugs in new clinical applications. In this work, all ...

New York, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Overview: The Antidepressant Drugs Market size is expected to reach USD 20.1 billion by 2024 and is further anticipated to reach USD 26.9 billion by ...

Importantly, the antidepressants do not seem to work in fighting cancer on their own. They need to be combined with anti-cancer drugs that stop tumors from hiding from the body's immune system.

There has been a new antidepressant on the market every two or three years. In 1987, the antidepressant fluoxetine (Prozac) was introduced. It had been tested by the FDA and found to be an ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

David Healy and David Menkes from Cardiff University in Britain and Andrew Herxheimer from the Cochrane Centre say in a new study that the newer antidepressants trigger violent behavior in people ...

The global antidepressant drugs market size was US$ 18.1 billion in 2021. The global antidepressant drugs market is forecast to grow to US$ 32 billion by 2030, registering a compound annual growth ...

Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.